Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

Soo Ok Lee, Wei Lou, Candace S. Johnson, Donald L. Trump, Allen C Gao

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

BACKGROUND. Elevated expression of interleukin-6 (IL-6) is implicated in the progression of hormone refractory prostate cancer. Previous studies demonstrated that IL-6 promotes androgen-independent growth of prostate cancer cells. In this study, the effect of IL-6 on apoptosis induced by androgen deprivation was investigated. METHODS. The effect of IL-6 on apoptosis induced by androgen deprivation in LNCaP cells was examined by cell death ELISA and Western blot using cleaved poly (ADP-ribose) polymerase (PARP) and caspase-9, as well as Bcl-XL and phosphorylated Bad. The Stat3 in IL-6-mediated anti-apoptosis in prostate cancer cells was examined using either dominant-negative or constitutively activated Stat3 mutants. RESULTS. Overexpression of IL-6 renders androgen sensitive LNCaP human prostate cancer cells more resistant to apoptosis induced by androgen deprivation. LNCaP cells undergo apoptosis after 72 hr of androgen deprivation, an outcome is largely absent in clones overexpressing IL-6 as measured by cell death ELISA and chromatin degradation assays. IL-6 over-expressing cells resulted in a significant decrease in the expression of cleaved PARP and cleaved caspase-9 as well as an increase in the expression of Bcl-XL and phosphorylated Bad. Addition of IL-6 antibody completely abolished the anti-apoptotic activity of IL-6. This protective effect of IL-6 was reversed by the expression of a dominant-negative Stat3 mutant, Stat3F. Furthermore, ectopic expression of a constitutively active Stat3 antagonized androgen deprivation-induced cell death of LNCaP cells. CONCLUSION. These results indicate that IL-6 protects androgen sensitive LNCaP cells from apoptosis induced by androgen deprivation, and Stat3 activation play an important role in IL-6-mediated anti-apoptosis in prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)178-186
Number of pages9
JournalProstate
Volume60
Issue number3
DOIs
StatePublished - Aug 1 2004
Externally publishedYes

Fingerprint

Androgens
Interleukin-6
Apoptosis
Prostatic Neoplasms
Cell Death
Poly(ADP-ribose) Polymerases
Caspase 9
Enzyme-Linked Immunosorbent Assay
Chromatin
Clone Cells
Western Blotting
Hormones

Keywords

  • Androgen-independence
  • Apoptosis
  • IL-6
  • Prostate cancer
  • Stat3

ASJC Scopus subject areas

  • Urology

Cite this

Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. / Lee, Soo Ok; Lou, Wei; Johnson, Candace S.; Trump, Donald L.; Gao, Allen C.

In: Prostate, Vol. 60, No. 3, 01.08.2004, p. 178-186.

Research output: Contribution to journalArticle

Lee, Soo Ok ; Lou, Wei ; Johnson, Candace S. ; Trump, Donald L. ; Gao, Allen C. / Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway. In: Prostate. 2004 ; Vol. 60, No. 3. pp. 178-186.
@article{473bf6836d4a462d92b92371d7f8c185,
title = "Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway",
abstract = "BACKGROUND. Elevated expression of interleukin-6 (IL-6) is implicated in the progression of hormone refractory prostate cancer. Previous studies demonstrated that IL-6 promotes androgen-independent growth of prostate cancer cells. In this study, the effect of IL-6 on apoptosis induced by androgen deprivation was investigated. METHODS. The effect of IL-6 on apoptosis induced by androgen deprivation in LNCaP cells was examined by cell death ELISA and Western blot using cleaved poly (ADP-ribose) polymerase (PARP) and caspase-9, as well as Bcl-XL and phosphorylated Bad. The Stat3 in IL-6-mediated anti-apoptosis in prostate cancer cells was examined using either dominant-negative or constitutively activated Stat3 mutants. RESULTS. Overexpression of IL-6 renders androgen sensitive LNCaP human prostate cancer cells more resistant to apoptosis induced by androgen deprivation. LNCaP cells undergo apoptosis after 72 hr of androgen deprivation, an outcome is largely absent in clones overexpressing IL-6 as measured by cell death ELISA and chromatin degradation assays. IL-6 over-expressing cells resulted in a significant decrease in the expression of cleaved PARP and cleaved caspase-9 as well as an increase in the expression of Bcl-XL and phosphorylated Bad. Addition of IL-6 antibody completely abolished the anti-apoptotic activity of IL-6. This protective effect of IL-6 was reversed by the expression of a dominant-negative Stat3 mutant, Stat3F. Furthermore, ectopic expression of a constitutively active Stat3 antagonized androgen deprivation-induced cell death of LNCaP cells. CONCLUSION. These results indicate that IL-6 protects androgen sensitive LNCaP cells from apoptosis induced by androgen deprivation, and Stat3 activation play an important role in IL-6-mediated anti-apoptosis in prostate cancer cells.",
keywords = "Androgen-independence, Apoptosis, IL-6, Prostate cancer, Stat3",
author = "Lee, {Soo Ok} and Wei Lou and Johnson, {Candace S.} and Trump, {Donald L.} and Gao, {Allen C}",
year = "2004",
month = "8",
day = "1",
doi = "10.1002/pros.20045",
language = "English (US)",
volume = "60",
pages = "178--186",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

AU - Lee, Soo Ok

AU - Lou, Wei

AU - Johnson, Candace S.

AU - Trump, Donald L.

AU - Gao, Allen C

PY - 2004/8/1

Y1 - 2004/8/1

N2 - BACKGROUND. Elevated expression of interleukin-6 (IL-6) is implicated in the progression of hormone refractory prostate cancer. Previous studies demonstrated that IL-6 promotes androgen-independent growth of prostate cancer cells. In this study, the effect of IL-6 on apoptosis induced by androgen deprivation was investigated. METHODS. The effect of IL-6 on apoptosis induced by androgen deprivation in LNCaP cells was examined by cell death ELISA and Western blot using cleaved poly (ADP-ribose) polymerase (PARP) and caspase-9, as well as Bcl-XL and phosphorylated Bad. The Stat3 in IL-6-mediated anti-apoptosis in prostate cancer cells was examined using either dominant-negative or constitutively activated Stat3 mutants. RESULTS. Overexpression of IL-6 renders androgen sensitive LNCaP human prostate cancer cells more resistant to apoptosis induced by androgen deprivation. LNCaP cells undergo apoptosis after 72 hr of androgen deprivation, an outcome is largely absent in clones overexpressing IL-6 as measured by cell death ELISA and chromatin degradation assays. IL-6 over-expressing cells resulted in a significant decrease in the expression of cleaved PARP and cleaved caspase-9 as well as an increase in the expression of Bcl-XL and phosphorylated Bad. Addition of IL-6 antibody completely abolished the anti-apoptotic activity of IL-6. This protective effect of IL-6 was reversed by the expression of a dominant-negative Stat3 mutant, Stat3F. Furthermore, ectopic expression of a constitutively active Stat3 antagonized androgen deprivation-induced cell death of LNCaP cells. CONCLUSION. These results indicate that IL-6 protects androgen sensitive LNCaP cells from apoptosis induced by androgen deprivation, and Stat3 activation play an important role in IL-6-mediated anti-apoptosis in prostate cancer cells.

AB - BACKGROUND. Elevated expression of interleukin-6 (IL-6) is implicated in the progression of hormone refractory prostate cancer. Previous studies demonstrated that IL-6 promotes androgen-independent growth of prostate cancer cells. In this study, the effect of IL-6 on apoptosis induced by androgen deprivation was investigated. METHODS. The effect of IL-6 on apoptosis induced by androgen deprivation in LNCaP cells was examined by cell death ELISA and Western blot using cleaved poly (ADP-ribose) polymerase (PARP) and caspase-9, as well as Bcl-XL and phosphorylated Bad. The Stat3 in IL-6-mediated anti-apoptosis in prostate cancer cells was examined using either dominant-negative or constitutively activated Stat3 mutants. RESULTS. Overexpression of IL-6 renders androgen sensitive LNCaP human prostate cancer cells more resistant to apoptosis induced by androgen deprivation. LNCaP cells undergo apoptosis after 72 hr of androgen deprivation, an outcome is largely absent in clones overexpressing IL-6 as measured by cell death ELISA and chromatin degradation assays. IL-6 over-expressing cells resulted in a significant decrease in the expression of cleaved PARP and cleaved caspase-9 as well as an increase in the expression of Bcl-XL and phosphorylated Bad. Addition of IL-6 antibody completely abolished the anti-apoptotic activity of IL-6. This protective effect of IL-6 was reversed by the expression of a dominant-negative Stat3 mutant, Stat3F. Furthermore, ectopic expression of a constitutively active Stat3 antagonized androgen deprivation-induced cell death of LNCaP cells. CONCLUSION. These results indicate that IL-6 protects androgen sensitive LNCaP cells from apoptosis induced by androgen deprivation, and Stat3 activation play an important role in IL-6-mediated anti-apoptosis in prostate cancer cells.

KW - Androgen-independence

KW - Apoptosis

KW - IL-6

KW - Prostate cancer

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=3242767803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242767803&partnerID=8YFLogxK

U2 - 10.1002/pros.20045

DO - 10.1002/pros.20045

M3 - Article

C2 - 15176047

AN - SCOPUS:3242767803

VL - 60

SP - 178

EP - 186

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 3

ER -